Interferon beta-1a
Interferon beta-1a is produced by recombinant technology in mammalian cells called Chinese Hamster Ovary (CHO) cells.
The product is produced as a glycoprotein and differs from interferon beta-1a because it has a different protein sequence and carbohydrates attached to the protein. Interferon beta-1a is used to treat patients with relapsing forms of multiple sclerosis.
